Price Alert

Septerna Inc. (SEPN)

NASDAQ: SEPN · Real-Time Price · USD

11.59

-0.13 (-1.11%)

At close: Aug 18, 2025, 3:59 PM

11.59

0.04%

After-hours: Aug 18, 2025, 04:43 PM EDT

-1.11% (1D)

Bid	11.48
Market Cap	516.52M
Revenue (ttm)	725K
Net Income (ttm)	-27.77M
EPS (ttm)	-7.58
PE Ratio (ttm)	-1.53
Forward PE	-5.31
Analyst	Buy

Ask	11.68
Volume	212,463
Avg. Volume (20D)	413,212
Open	11.73
Previous Close	11.72
Day's Range	11.57 - 11.89
52-Week Range	4.17 - 28.99
Beta	4.26

About SEPN

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol SEPN

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SEPN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Septerna Inc. is scheduled to release its earnings on Nov 19, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 months ago

-2.77%

SEPN stock has given up its prior gain. Septerna s... Unlock content with Pro Subscription

3 months ago

-2.77%

Septerna shares are trading higher after the company reported better-than-expected Q1 sales results.

News

1 month ago · benzinga.com

Analyst Flags Septerna As Undervalued Biotech Play With Significant Upside

On Monday, HC Wainwright initiated coverage on Septerna, Inc. SEPN, citing a next-generation drug design platform aimed at hitherto-undruggable targets.

2 months ago · marketbeat.com

Analysts Think These Stocks Could More Than Double in Value

Persistent volatility has plagued the S&P 500 for much of 2025, prompting widespread caution among many investors amid the uncertainties of trade battles, tariffs, domestic policy, and more. Investors...

2 months ago · zacks.com

Does Septerna, Inc. (SEPN) Have the Potential to Rally 151.27% as Wall Street Analysts Expect?

The mean of analysts' price targets for Septerna, Inc. (SEPN) points to a 151.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among ...